mohammad7moosav Profile Banner
Mohammad Moosavi Profile
Mohammad Moosavi

@mohammad7moosav

Followers
275
Following
2K
Media
41
Statuses
297

@CDTLifETIME PhD fellowship, @remedinuig, @curamdevices, Ocular Therapeutics Lab 👁️

Joined September 2020
Don't wanna be here? Send us removal request.
@mohammad7moosav
Mohammad Moosavi
23 days
End of the #PhD era! ✅ 🎓 Officially a Dr. 😎 Grateful for all the lessons during these years and excited for the future adventures ✌🏼✨
1
0
4
@mohammad7moosav
Mohammad Moosavi
3 months
Thrilled to share that I successfully defended my PhD 🎓✨ within @CDTLifETIME. Research on cytokine-licensed #MSC_EVs for #immunomodulation, tissue #regeneration & #ocular_delivery 👁️ Grateful to my supervisor, examiners, advisors & amazing collaborators 🤍🍀
2
0
9
@ThomasR55937842
Thomas Ritter 🇩🇪🇪🇺🇮🇪
4 months
Great to see @mohammad7moosav presenting his interesting work at the annual Irish society for immunology meeting in Galway @CURAMdevices @uniofgalway @GalwayRNA
0
5
14
@REMEDIGalway
REMEDI
5 months
Last week we celebrated 20 years of REMEDI with a two-day summit highlighting two decades of groundbreaking research. We welcomed Prof. Giebel as keynote speaker & bid farewell to Tina Harte who is moving to pastures new. Here's to another 20 years of REMEDI innovation!
1
6
17
@EllenDonohoe9
Ellen Donohoe
5 months
🔬If you're interested in #ExtracellularVesicles and MSC-EV therapy, check out our new publication: "Small extracellular vesicles secreted from TGF-β1-licensed mesenchymal stromal cells reduce inflammation-associated injury following corneal alkali burn" https://t.co/WdRCadwVbf
@ThomasR55937842
Thomas Ritter 🇩🇪🇪🇺🇮🇪
5 months
📢Great news to see our recent work lead by @EllenDonohoe9 on therapeutic efficacy of MSC-EVs in preclinical eye model published. @Galway_Research @Researchirel @restorevis_eu @CURAMdevices @aideenryan1 @olivertreacy1 https://t.co/OP5p1ZQMZO
0
5
6
@ThomasR55937842
Thomas Ritter 🇩🇪🇪🇺🇮🇪
5 months
📢Great news to see our recent work lead by @EllenDonohoe9 on therapeutic efficacy of MSC-EVs in preclinical eye model published. @Galway_Research @Researchirel @restorevis_eu @CURAMdevices @aideenryan1 @olivertreacy1 https://t.co/OP5p1ZQMZO
1
7
13
@mohammad7moosav
Mohammad Moosavi
8 months
Last week i attended at @IsevOrg annual meeting in Vienna, presenting our work on #MSC_EVs, #immunomodulation, #tissue_regenration, and their #Ocular_delivery Fantastic projects and technologies🔝 Thanks to @CDTLifETIME and @GalwayCMNHS for supporting this trip and this project
0
0
11
@mohammad7moosav
Mohammad Moosavi
8 months
We’re off to a full-house start at #ISEV2025! @IsevOrg
4
0
9
@IsevOrg
ISEV
8 months
🤩 Did you see the graphical abstract that is created live during Education Day? Great artwork by Robert Six (R6) #ISEV2025
5
3
19
@mohammad7moosav
Mohammad Moosavi
8 months
Split the G , and getting ready for pints of science at #isev2025 ! @IsevOrg 📍Dublin airport 🇮🇪
6
1
10
@Irishimmunology
Irish Immunology
9 months
📣 ***Online Registration & Abstract Submission are now open for the ISI Meeting 2025!*** ➡️ Online links available at: https://t.co/jMXUeSvsFQ ➡️ ISI 2025 will be hosted at @uniofgalway on 21-22 August. • Abstract deadline: 1st May. • Earlybird Registration until 15th July.
0
18
21
@ThomasR55937842
Thomas Ritter 🇩🇪🇪🇺🇮🇪
9 months
Delighted to share our latest work led by @Jiemin_Wang_17 comparing therapeutic efficacy of large and small apoptotic bodies derived from MSCs https://t.co/vFcTE3y8fc @restorevis_eu @Galway_Research @CURAMdevices @Researchirel @aideenryan1
0
3
13
@ThomasR55937842
Thomas Ritter 🇩🇪🇪🇺🇮🇪
10 months
the final pdf of our collaborative work investigating MSC-EVs for therapeutic treatment of ocular disorders is now freely available online @FilippoBonelli1 @mohammad7moosav @CURAMdevices @Galway_Research @GalwayRNA
0
3
5
@mohammad7moosav
Mohammad Moosavi
10 months
My first first-author PhD paper is out! Grateful for the collaboration between REMEDI & Venice Eye Bank. Our study highlights the therapeutic potential of MSC-EVs for corneal epithelial damage & regenerative medicine. Huge thanks to all co-authors. https://t.co/C7eTxvD7mw
4
1
32
@uniofgalway
Ollscoil na Gaillimhe | University of Galway
10 months
Dr Aideen Ryan @GalwayCMNHS (College of Medicine, Nursing and Health Sciences) spoke to Silicon Republic about her research focused on enhancing the body’s immune response to cancers. Read the article:
Tweet card summary image
siliconrepublic.com
University of Galway’s Dr Aideen Ryan is looking at mechanisms in supportive tissue cells with the aim of enhancing the body’s immune response to cancers.
1
5
34
@EimearBDolan
Eimear Dolan
11 months
📢Recruiting a postdoctoral researcher to join our team in @Bio_Eng_NUIG. Our research includes medical implant design, mechanotherapies, drug- and cell-based therapies & translation of our discoveries. Get in touch for informal enquires. RTs welcome! https://t.co/Okv9LK8GJV..
Tweet card summary image
nature.com
Applications are invited from suitably qualified candidates for a full-time fixed term position as a Postdoctoral Researcher with Dr Eimear Dolan’s...
0
12
37
@aideenryan1
Aideen Ryan
11 months
Come work with us on an exciting project to investigate the role of sialylation in regulating anti-tumour immune responses in oesophageal cancer @CancerUniGalway @GalwayCMNHS @Researchirel @sitcancer
@JoanneLysaght
JL
11 months
Post-Doctoral position available in my lab in collaboration with @aideenryan1, examining novel immune evasion strategies in upper-gastrointestinal cancer, details below. @CancerInstIRE @TCDTMI @TrinityMed1 @Irishimmunology @News_IACR @sitcancer @hrbireland @AlCRIproject @y_efis
0
7
13
@ThomasR55937842
Thomas Ritter 🇩🇪🇪🇺🇮🇪
1 year
Delighted to see so many @restorevis_eu researchers presenting their projects today at @EVER_connect in Valencia. Great progress made already towards the development of novel therapies for rare corneal disease @CURAMdevices @Galway_Research @EU_HaDEA
2
4
8